Award presented during keynote lunch at the 2013 BIO International Convention.
April 21, 2013
/PRNewswire-USNewswire/ -- The Chemical Heritage Foundation (CHF) and the Biotechnology Industry Organization (BIO) have selected
as the winner of the 2013 Biotechnology Heritage Award. The award will be presented during a keynote lunch on
Tuesday, April 23
, at BIO's
annual international convention
, which begins tomorrow in
has pioneered with brilliance in steroid chemistry; innovated with legendary success in the pharmaceutical industry; and recruited, mentored, and guided individuals of great talent to stellar careers. He unites in his person European charm, Hispanic courtesy, and American entrepreneurial spirit," says
James C. Greenwood
, President and CEO of BIO. "George led the development of the oral contraceptive pill, served as chairman of the corporation that brought it to the global market, and thereby permanently changed world culture."
About George Rosenkranz
joined Syntex Corporation in 1945 and retired as CEO and board chairman in 1981. During his years with Syntex, Rosenkranz created and guided an academic research group of star-studded brilliance, which included
, first as his junior collaborators, then as his lifelong friends. Revolutionary advances in the intellectual understanding of and production techniques for steroid drugs were developed under Rosenkranz's direction, using native Mexican plant sources as raw materials. Syntex became the leading supplier of the oral contraceptive pill and other corticoids.
Rosenkranz's accomplishments have encompassed every aspect of the steroid hormone industry. He holds over 150 patents and has published more than 300 research articles on steroid hormones.